Cost utility analysis of the SQ® HDM SLIT-tablet in house dust mite allergic asthma patients in a German setting
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-7022
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cost utility analysis of the SQ® HDM SLIT-tablet in house dust mite allergic asthma patients in a German setting ; volume:6 ; number:1 ; day:7 ; month:9 ; year:2016 ; pages:1-8 ; date:12.2016
Clinical and translational allergy ; 6, Heft 1 (7.9.2016), 1-8, 12.2016
- Creator
-
Hahn-Pedersen, J.
- Contributor
-
Worm, M.
Green, W.
Andreasen, J. Nørgaard
Taylor, M.
SpringerLink (Online service)
- DOI
-
10.1186/s13601-016-0127-6
- URN
-
urn:nbn:de:1111-201610064002
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hahn-Pedersen, J.
- Worm, M.
- Green, W.
- Andreasen, J. Nørgaard
- Taylor, M.
- SpringerLink (Online service)
Other Objects (12)
A Real-Life One-Year Non-Interventional Study Assessing Safety, Tolerability, and Treatment Outcome of the SQ HDM SLIT-Tablet (Acarizax®) in House Dust Mite Allergic Rhinitis With or Without Asthma
Clinical benefits with 300 IR HDM SLIT tablet in Europeans with house dust mite allergic rhinitis: Post hoc analysis of a large phase 3 trial
New perspectives in allergen specific immunotherapy driven by big trials with house dust mite sublingual SQ® tablets
slit
Allergen immunotherapy in house dust mite-associated allergic rhinitis: efficacy of the 300 IR mite tablet
SQ
"SQ"
SQ
SQ
SQ
Nachmeldg. Formblatt SQ I und SQ III
SQ ZET
A Real-Life One-Year Non-Interventional Study Assessing Safety, Tolerability, and Treatment Outcome of the SQ HDM SLIT-Tablet (Acarizax®) in House Dust Mite Allergic Rhinitis With or Without Asthma
Clinical benefits with 300 IR HDM SLIT tablet in Europeans with house dust mite allergic rhinitis: Post hoc analysis of a large phase 3 trial
New perspectives in allergen specific immunotherapy driven by big trials with house dust mite sublingual SQ® tablets
slit
Allergen immunotherapy in house dust mite-associated allergic rhinitis: efficacy of the 300 IR mite tablet
SQ
"SQ"
SQ
SQ
SQ
Nachmeldg. Formblatt SQ I und SQ III
SQ ZET
A Real-Life One-Year Non-Interventional Study Assessing Safety, Tolerability, and Treatment Outcome of the SQ HDM SLIT-Tablet (Acarizax®) in House Dust Mite Allergic Rhinitis With or Without Asthma
Clinical benefits with 300 IR HDM SLIT tablet in Europeans with house dust mite allergic rhinitis: Post hoc analysis of a large phase 3 trial
New perspectives in allergen specific immunotherapy driven by big trials with house dust mite sublingual SQ® tablets
slit
Allergen immunotherapy in house dust mite-associated allergic rhinitis: efficacy of the 300 IR mite tablet
SQ
"SQ"
SQ
SQ
SQ
Nachmeldg. Formblatt SQ I und SQ III